Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?

@article{DomnguezMuoz2011PancreaticER,
  title={Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency: when is it indicated, what is the goal and how to do it?},
  author={Juan Enrique Dom{\'i}nguez-Mu{\~n}oz},
  journal={Advances in medical sciences},
  year={2011},
  volume={56 1},
  pages={
          1-5
        }
}
Pancreatic exocrine insufficiency with steatorrhea is a major consequence of pancreatic diseases (e.g. chronic pancreatitis, cystic fibrosis, severe acute necrotizing pancreatitis, pancreatic cancer), extrapancreatic diseases like celiac disease and Crohn's disease, and gastrointestinal and pancreatic surgical resections. Recognition of this entity is highly relevant to avoid malnutrition-related morbidity and mortality. Therapy of pancreatic exocrine insufficiency is based on the oral… 

Figures from this paper

[Croatian guidelines for the management of pancreatic exocrine insufficiency].
TLDR
Pancreatic exocrine insufficiency is a major consequence of pancreatic diseases like celiac disease and Crohn's disease, and gastrointestinal and pancreatic surgical resections, and recognition of this entity is highly relevant to avoid malnutrition-related morbidity and mortality.
Pancreatic enzyme replacement therapy during pancreatic insufficiency.
  • A. Berry
  • Medicine
    Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
  • 2014
TLDR
The conditions that cause pancreatic insufficiency, how to determine if the patient is malabsorbing, and the best use of pancreatic enzyme replacement therapy for treatment in these conditions are clarified.
Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.
TLDR
Approaches for improving the results of enzyme therapy are described including changing to, or adding, a different product, adding non-enteric coated enzymes, use of antisecretory drugs and/or antacids, and changing the timing of enzyme administration.
Rational Use of Pancreatic Enzymes for Pancreatic Insufficiency and Pancreatic Pain.
TLDR
The rational use of enteric coated and unprotected replacement pancreatic enzymes for treatment of malabsorption due to pancreatic insufficiency and for pancreatic pain is described and mechanisms causing pain that may be amenable to therapy with pancreatic enzyme mechanisms are focused on.
Practical guide to exocrine pancreatic insufficiency – Breaking the myths
TLDR
This opinion piece aims to address the existing myths, remove the current confusion, and function as a practical guide to the diagnosis and treatment of EPI.
Pancreatic enzyme replacement therapy after gastric resection: An update.
Up-To-Date View on the Clinical Manifestations and Complications of Chronic Pancreatitis
TLDR
Patients with chronic pancreatitis are at increased risk for pancreatic cancer influenced by smoking, alcohol abuse, chronic inflammation and pancreatic stellate cells over-proliferation, and could be further complicated with splenic vein thrombosis, pseudocysts, duodenal or biliary obstruction, pseudoaneurysm and Pancreatic duct stones which might require endoscopic or surgical treatment.
Severe Pancreatic Dysfunction But Compensated Nutritional Status in Monogenic Pancreatic Disease Caused by Carboxyl-Ester Lipase Mutations
TLDR
Pancreatic exocrine dysfunction in CEL-MODY is associated with severely reduced acinar and moderately reduced ductal dysfunction, and despite severely reduced exocrine pancreatic function, Cel-Mody patients revealed only minor signs of malnutrition.
Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy.
  • Li Li, S. Somerset
  • Medicine, Biology
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2014
Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel
TLDR
A panel of Canadian gastroenterologists has conducted a critical review of the literature on PEI and PERT and has developed practical diagnostic and treatment recommendations for PCPs that provide guidance on identifying patients at risk of PEI, the triggers for PEI testing and referral, and best practices for co-managing patients with confirmed PEI.
...
...

References

SHOWING 1-10 OF 26 REFERENCES
Pancreatic enzyme therapy for pancreatic exocrine insufficiency
TLDR
The present article critically reviews current therapeutic approaches to pancreatic exocrine insufficiency and recommends enzymes in the form of enteric-coated minimicrospheres to avoid acid-mediated lipase inactivation and ensures gastric emptying of enzymes in parallel with nutrients.
Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts
TLDR
It is hypothesised that potent inhibition of gastric acid secretion, by avoiding bile acid precipitation and allowing lipase release within the proximal gut, may improve the therapeutic efficacy of enteric coated pancreatic enzymes for EPI.
Human pancreatic exocrine response to nutrients in health and disease
Optimal digestion and absorption of nutrients requires a complex interaction among motor and secretory functions of the gastrointestinal tract. Digestion of macronutrients is a prerequisite for
Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy?
TLDR
An appropriate clinical response to enzyme substitution therapy does not allow the prediction of a normal nutritional status in patients with chronic pancreatitis.
Fate of oral enzymes in pancreatic insufficiency.
TLDR
It is suggested that enteric coated pancreatin nearly corrects severe pancreatic steatorrhoea as luminal enzyme activity in the ileum was enhanced to a greater extent than in the duodenum, and consequently the absorptive potential of the small bowel was only partially utilised.
Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes
TLDR
omeprazole improves fat digestion and absorption in cystic fibrosis patients with residual faecal fat loss despite maximal pancreatic enzyme substitution.
A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency
TLDR
Enteric-coated, delayed-release (Minimicrospheres) pancrelipase capsules are an effective treatment for steatorrhea associated with pancreatic insufficiency in patients with cystic fibrosis.
Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy
TLDR
Famotidine is a useful adjuvant to pancreatic enzyme therapy in patients with severe pancreatic insufficiency and persistent maldigestion on large doses of pancreatic supplements; in fact, famotidine improves not only fat absorption but the nutritional status of the patients.
Hydrogen Breath Test with Glucose in Exocrine Pancreatic Insufficiency
TLDR
The results suggest that a positive glucose test indicating overgrowth is relatively common in exocrine pancreatic insufficiency due to chronic pancreatic, especially in patients with previous gastroduodenal surgery.
Survival of human pancreatic enzymes during small bowel transit: effect of nutrients, bile acids, and enzymes.
TLDR
Intraluminal nutrients increase survival of enzyme activities in the proximal intestine after absorption of nutrients, the action of chymotrypsin and bile acids decrease lipolytic activity more than activity of other enzymes.
...
...